About Squalene
The squalene is obtained by the hydro generation process which can be naturally found in skin lipids of animals, plants, and humans. It prevents moisture loss of skin along with maintaining flexibility and suppleness of the skin. It works by balancing the oil production and provides clear and healthy skin. Squalene is used in food, cosmetics, supplements, etc because of its various health benefits like its consists of anti-aging, antioxidants, and other anti-inflammatory properties required for the skin.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Kishimoto Special Liver Oil Co Ltd. (Japan), SeaDragon Marine Oils Limited (New Zealand), Amyris, Inc. (United States), Maruha Nichiro Corporation (Japan), Sophim (France), Nucelis (United States), Empresa Figueirense de Pesca (Portugal), Gracefruit Limited (United Kingdom) and New Zealand Green Health Ltd (New Zealand) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Squalene market by and Region.
On the basis of geography, the market of Squalene has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User Industry, the sub-segment i.e. Cosmetics will boost the Squalene market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Supermarket will boost the Squalene market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Source, the sub-segment i.e. Animal Source will boost the Squalene market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Application of Squalene in Various Food Supplements Because of its Health Benefits
Market Growth Drivers:
Demand for Naturally Extracted Skin Products and Increasing Production of Food Products with High Antioxidant Levels
Challenges:
Risk of Perishability Involved with Squalene Products
Restraints:
Regulatory Standards and Guidelines Involved with Production and Exports of Squalene
Opportunities:
Continuous Research and Development in Squalene Compound and Surging Demand for Squalene in Pharmaceutical Products
Market Leaders and their expansionary development strategies
In February 2023, Givaudan, the world’s largest fragrance and flavors supplier, acquired certain cosmetic ingredients from California-based biotechnology player Amyris, including its sugarcane-derived squalane, a sustainable alternative to that found in deep-sea shark livers.
In October 2023, Evonik’s non-animal-derived squalene PhytoSquene is now available produced under GMP. Launched last year, PhytoSquene, is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms
"FDA licensed (approved) the second vaccine for use in the United States for the prevention of H5N1 influenza, commonly referred to as avian influenza or “bird flu.” The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, is the first adjuvanted influenza vaccine approved by FDA and is for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine. The vaccine contains the adjuvant AS03, an oil-in-water emulsion. The AS03 adjuvant is made up of the oily compounds, D, L-alpha-tocopherol (vitamin E), and squalene, and an emulsifier known as polysorbate 80, and water containing small amounts of salts."
Key Target Audience
Squalene Producers, Squalene International Traders, Squalene Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Upstream and Downstream Buyers and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.